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PENGAYAAN KROMATOGRAFI KUASINODE YANG BIOAKTIF DALAM 





Akar Eurycoma longifolia digunakan sebagai ubat herba tradisional untuk 
meningkatkan libido dan menambahbaik kesihatan mengandungi sebatian kuasinode 
yang pahit dan alkaloid kantinon, yang hanya boleh dididapati dalam tumbuh-
tumbuhan berasal dari keluarga Simaroubaceae. Kuasinode terutamamya dengan 
tulang belakang karbon 20 seperti eurikomanon (EN), 13α(21)-epoksieurikomanon 
(EP) dan kuasinoid minor 13,21-dihidroeurikomanon (DHY) mempunyai aktiviti 
farmakologi anti-malaria, anti-deman dan anti-ketidaksuburan. Dalam kajian ini, tiga 
jenis resin bermakroliang Diaion HP-20, SP-700 dan SP-207 telah dikaji untuk fraksi 
EN dan DHY dalam ekstrak metanol E. longifolia. Hasil kajian mengesahkan Diaion 
HP-20 paling sesuai dalam pengayaan EN dan DHY memandangkan fraksi-EN dan 
fraksi-DHY masing-masing telah diperkayakan sebanyak  30.40 % dan 13.96 % w/w, 
berbanding dengan 6.13 % and 0.54 % dalam ekstrak asal E. longifolia. Sementara itu, 
satu kaedah kromatograifi cecair berprestasi tinggi yang mudah dan boleh dipercayai 
dengan pengesanan ultraungu telah dibangunkan untuk penentuan kandungan EN dan 
DHY dalam fraksi-fraksi tersebut. Seterusnya, fraksi-EN dan fraksi-DHY yang 
diperolehi ini digunakan dalam kajian farmakokinetik. Didapati bahawa DHY 
mencapai puncak kepekatan (Cmax) dan jumlah luas di bawah keluk (AUC0-) yang 
lebih tinggi daripada EN selepas pemberian secara oral. Kedua-dua sebatian 
menunjukkan biokeperolehan mutlak yang rendah (< 5 %). Namun begitu, 
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biokeperolehan mutlak DHY (1 %) adalah lebih tinggi daripada EN (0.3 %) sebanyak 
tiga kali ganda. Seterusnya, keupayaan fraksi-EN dan fraksi-DHY dalam 
penambahbaikan spermatogenesis in vivo tikus telah dikaji. Kiraan sperma, motiliti 
dan morfologi sperma telah dilaksanakan. Kumpulan tikus yang dirawat dengan fraksi-
EN mencatat bilangan sperma (48.60 x106/mL/g testis) yang paling tinggi, diikuti oleh 
kumpulan rawatan fraksi-DHY (39.24 x106/mL/g testis) dan kumpulan kawalan biasa 
(25.87 x106/mL/g of testis), mencadangkan EN sebagai sebatian berpotensi tinggi 
dalam meningkatkan spermatogenesis berbanding dengan DHY. Di samping itu, tiada 
perbezaan signifikan motiliti dan morphologi sperma diperhatikan dalam ketiga-tiga 
kumpulan tikus tersebut. Di samping itu, satu model tikus oligospermik direka untuk 
menilai keberkesanan fraksi-EN dan fraksi-DHY dalam peningkatan spermatogenesis 
yang tidak normal. Tikus-tikus oligospermik yang dirawat dengan fraksi-EN (37.69 x 
106/mL/g) dan fraksi-DHY (30.08 x 106/mL/g) menunjukkan peningkatan dalam 
jumlah sperma (P < 00.5) berbanding kumpulan kawalan negatif. Kesimpulannya, 
walaupun DHY mempunyai kelebihan biokeperolehan tiga kali ganda lebih tinggi 
daripada EN, namun fraksi-EN lebih berkesan dalam meningkatkan pengeluaran 
sperma daripada fraksi-DHY. Ini menunjukkan bahawa bioaktiviti kuasinode bukan 
sahaja dipengaruhi oleh faktor-faktor farmakokinetik dan fizikokimia tetapi juga 
dipengaruhi faktor-faktor farmakodinamik seperti interaksi molekul intrinsik dengan 
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Eurycoma longifolia Jack roots, traditionally used as herbal remedies for 
increasing libido and better health conditions, contain a high content of quassinoids, 
the bitter substances and alkaloidal canthinones, indigenous in the Simaroubaceae 
family that are responsible for the plant pharmacological properties. Amongst the 
quassinoids, the 20-carbon eurycomanone (EN), 13α(21)-epoxyeurycomanone (EP), 
eurycomanol (EL) and 13α,21-dihydroeurycomanone (DHY), possess anti-malarial, 
anti-ulcer, anti-pyretic, anti-osteoporosis, aphrodisiac and anti-infertility properties. In 
the present study, the chromatographic separation employing macroporous resin 
Diaion HP-20, Sepabeads SP-700 and SP-207 were evaluated for the enrichment of 
EN and DHY in E. longifolia methanolic extract. Results showed that among the three 
macroporous resin, Diaion HP-20 performed the best enrichment and separation 
characteristics. After single chromatographic fractionation with Diaion HP-20, the 
content of EN and DHY were increased from 6.13 % and 0.54 % to 30.40 % to 13.96 % 
w/w, respectively. Meanwhile, a simple and reliable high performance liquid 
chromatography with ultraviolet detection method was developed and validated for the 
determination of EN and DHY. Subsequently, the EN-rich and DHY-rich fractions 
were subjected to pharmacokinetic evaluation in rats. The present finding indicated 
that DHY was able to achieve a higher peak concentration (Cmax) and total area under 
the curve (AUC0-∞) compared to those of EN in oral dosing. The absolute 
bioavailability of both compounds remained low (< 5 %) but DHY showed a 
significantly higher bioavailability (1 %) than EN (0.3 %) which may be attributed to 
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the slightly higher lipophilicity of DHY. Subsequently, the EN-rich and DHY-rich 
fraction were tested for in vivo spermatogenesis activity. Sperm, count, motility and 
morphology at the cauda epididymal of the rats were carried out. The animals treated 
with EN-rich fraction scored the highest increase in sperm count of 48.60 x 106/mL/g 
of testis, followed by DHY-rich treated rats (39.24 x 106/mL/g of testis) and control 
group (25.87 x 106/mL/g of testis), suggested that EN was more potent than DHY in 
the improvement of spermatogenesis. However, there were no significant difference 
in sperm motility and morphology among the treated rats and control group. In addition, 
an oligospermic rat model was designed by using andrographolide isolated from 
Andrographis paniculata to evaluate the efficacy of EN and DHY in the augmentation 
of abnormal spermatogenesis. Oligospermic rats administered with EN-rich fraction 
(37.69 x 106/mL/g) and DHY-fration (30.08 x 106/mL/g) reported significant (P < 00.5) 
increase in sperm count compared to the negative control group given andrographolide 
only. In conclusion, despite DHY having a three-fold higher oral bioavailability than 
EN, EN-rich fraction was more potent in enhancing sperm production than DHY-rich 
fraction. These results indicated that the bioactivity of the quassinoids may be 
governed not only by the pharmacokinetic and physicochemical factors but also 
pharmacodynamics factors such as their intrinsic molecular interaction with the target 
site of action. 
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1.1 Infertility overview 
Infertility is a reproductive system disease which is the disability of couples to 
conceive after one year of unprotected sexual intercourse (WHO, 2017). There are 60 
to 80 million of people or 8 % to 12 % of couples around the world suffering from 
infertility problems with the highest rate in middle east countries, followed by Europe 
and America (Agarwal et al., 2015; Sahay & Reddy, 2006). In Malaysia, fertility rate 
has gradually declined from 2.78 to 2.06 children per household since year 2005 to 
2015 based on the statistics provided by Department of Statistics in Malaysia (Ho, 
2017). According to Dr. Agilan Arjunan, an in vitro fertilization (IVF) specialist of the 
Kuala Lumpur Fertility Centre, male infertility in the past ten years had increased 
approximately 50 % in Malaysia (Bernama, 2015). Infertility has always been alleged 
as a predominantly female disorder. However, 50 % of infertility problems among 
couples were attributed to the male partner (Anawalt, 2013). The true extent of male 
infertility is not well reported and underestimated owing to sociodemographic 
constraints.  
 
Semen analysis is the basis step in evaluating male fertility disorder where poor 
semen parameters lower the chances of pregnancy. The normal concentration of sperm 
count for a healthy man is between 40 million to 300 million per mL, whereas a count 
below 10 million per mL is considered as low sperm count or oligospermia (Jungwirth 
et al., 2012). The proposed normal healthy value for semen volume, pH, total sperm 
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count, motility, viability and white blood cell per ejaculate are ≥ 1.5 mL, ≥ 7.2, ≥ 39 
million sperm, ≥ 40 %, ≥ 58 % and less than 1 million white blood cell per mL, 
respectively (WHO, 2010). Following semen analysis, WHO (2010) recommended 
andrological investigations when the semen analysis of patients is abnormal in a 
duplicate test in order to define a diagnosis. Andrological investigations include 
hormonal assessments (level of testosterone, follicle-stimulating hormone and 
luteinizing hormone) and testicular biopsy to govern the severity of infertility of a 
patient. 
 
Clinically, male infertility can be distributed into four main groups:  
pretesticular disorder (hypothalamic or pituitary disorder), testicular disorder, post 
testicular (sperm transport disorder) and idiopathic (Sahay & Reddy, 2006). An 
epidemiology study published that majority of male infertility diagnosis fall into the 
idiopathic group owing to seminal abnormalities with unknown causes, followed by 
varicocele, accessory gland infection, immunological factor, ejaculatory inadequacy 
and genetic abnormality (Irvine, 1998). Pretesticular disorder is related to endocrine 
problems, and coital disorder such as hypogonadotropic hypogonadism, erectile 
dysfunction and ejaculatory failure (Kretser, 1997). Hypothalamic or pituitary disease 
is a less common aetiology in male infertility. Hypogonadism refers to the low 
physiological level of testosterone in male with associated signs or symptoms of 
abnormal spermatozoa production such as reduction of libido and erectile dysfunction. 
Primary hypogonadism is the failure of testes to produce sufficient testosterone to react, 
causing elevation of FSH and LH level. It can be caused by testicular injury, tumour, 
chemotherapy, congenital defects or testicular infectious disease. Secondary 
hypogonadism is the inability of hypothalamus to stimulate GnRH to secrete FSH and 
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LH (Dandona & Rosenberg, 2010). Insufficient secretion of FSH and LH has a direct 
impact on secondary sexual development and fertility. Testicular factors include 
chromosomal abnormalities, congenital disorder and autosomal karyotype 
abnormalities. The most common example is Kallmann syndrome owing to Y 
chromosome deletions (de Roux et al., 2003). Heat, drugs, irradiation and torsion will 
also lead to testicular disease. Post-testicular factors involve sperm transportation 
disorder in vas deferens and epididymis. It could be due to vasectomy, congenital 
issues and idiopathic (Kretser, 1997). Apart from that, male infertility may well arise 
from social and environmental factors such as aging, lifestyle habits, stress relationship, 
occupational exposure and scrotal temperature. 
 
Existing therapeutic treatment for male infertility includes oral medications, 
testicular surgery, in vitro fertilization and intracytoplasmic fertilization. Synthetic 
drugs such as sildenafil (Viagra) and tadalafil (Cialis) are commonly prescribed to treat 
erectile dysfunction by stimulating nitric oxide that activates cAMP to dilate the corpus 
luteum. Clomiphene citrate is an estrogen inhibitor that has proven to increase the 
production of FSH and LH in men (Choy & Ellsworth, 2012). Testosterone 
replacement therapy is another popular alternative to increase testosterone either 
through injections, oral medication or topical administration.  However, some of the 
drugs bring about undesirable side effects (Tharakan & Manyam, 2005). For instances, 
Viagra and Cialis are known to cause negative side effects such as headache, muscle 
pain, blurred vision and exert dangerous drug-drug interactions (Melnyk & Marcone, 
2011). Although testicular surgery, in vitro fertilization or intracytoplasmic sperm 
injection may be other alternatives, the surgery does not completely assure pregnancy 
and is very costly. 
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Natural herbs which are believed to be less harmful have been sought after as 
alternatives for increasing men libido by our ancestors. A herb is a plant or plant part 
used for its scent, flavor or therapeutic properties, and medicinal products made from 
them are frequently taken to improve health as dietary supplements (Jarukamjorn & 
Nemoto, 2008). In fact, 50 % of the drugs available in the market are of natural origin. 
For instances, aspirin, digitoxin, morphine, quinine and pilocarpine are drugs that 
derived from plant and has been widely used as pain reliever, heart failure medication, 
pain medication, anti-malarial drug and cholinergic agent, respectively (Balunas & 
Kinghorn, 2005). Thus, it is practical and important to extract bioactive ingredients 
from plants for the incessant development of potent drug. For examples, Tribulus 
terrestris, a Mediterranean plant belongs to the family Zygophyllaceae known as 
“puncture vine” was claimed to be beneficial in improving men virility by regulating 
male hormone level. The major bioactive compound found in this plant is protodioscin, 
a steroidal glycoside of furostanol type. Animal study conducted on rabbits and rats 
feeding on the plant extract reported significant increase in the level of serum 
testosterone, dihydrotestosterone and dehydroepiandrosterone in a dose dependent 
manner (Gauthaman & Ganesan, 2008).  
 
In Malaysia, Eurycoma longifolia which is known as Tongkat Ali is an 
indigenous plant found in Southeast Asia. It has been traditionally use as a tonic to 
improve general health, sexual prowess, to treat fever, syphilis and afterbirth by the 
locals and aborigines. Earlier phytochemical research showed that the organic root 
extract of E. longifolia increased penis reflexes and the frequency of ejaculation in rats 
(Ang et al., 2001). This led to the interests in isolation of bioactive compounds from 
this plant. It was discovered that E. longifolia contained mainly quassinoids, alkaloids, 
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tricullane-type triterpenes, biphenylneolignans and squalene derivatives (Bhat & 
Karim, 2010). The major bioactive component in E. longifolia was identified as 
quassinoids, degraded triterpenes that were indigenously found in Simaroubeceae 
plants. The quassinoids in E. longifolia is gaining attention owing to their interesting 
pharmacology activities such as antiplasmodial activity, cytotoxicity, ergogenic 
effects, anti-diabetic and aphrodisiac properties. It was identified that the major 
quassinoid, eurycomanone found in E. longifolia increased testosterone level in rats 
by acting as an aromatase inhibitor that inhibited the transformation of testosterone to 
estrogen (Low et al., 2013a).  
 
Enrichment of bioactive compounds in plant extracts is important as a 
preliminary step in manufacturing phytochemical-rich products. Additionally, the 
enrichment method should be established and optimized as a simple, low cost and 
reproducible process. Although extensive pharmacological and chemical studies have 
been carried out on E. longifolia, further rigorous testing and ratification on the 
bioactive components in E. longifolia is still needed to ascertain their pharmaceutical 
value as a therapeutic product.  
 
1.1.1  Current therapeutic approach on male infertility 
Current approach on male infertility focuses on testosterone replacement therapy, oral 
medications, assisted reproductive technology and in vitro fertilization. Beside the oral 
capsule or tablet testosterone administration, androgen can be boosted via 
intramuscular injections, transdermal patches, transdermal gel, buccal tablets and 
subcutaneous pellets. Common anti-estrogen drugs are clomiphene citrate, tamoxifen, 
toremifen and raloxifen (Dabaja & Schlegel, 2014). It stimulates the production of 
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testosterone by inhibiting the negative feedback of estrogen to the hypothalamic 
pituitary axis, thereby increasing the release of FSH and LH that stimulate Leydig cells 
to produce more testosterone (Choy & Ellsworth, 2012). Although clomiphene citrate 
showed beneficial outcome, it has not been legally approved by Food and Drug 
Administration for hypogonadism treatment. The side effects are minor nausea, 
dizziness, weight gain and fluid retention (Ramasamy et al., 2014). The contradictions 
of testosterone replacement therapy are risk of male breast cancer, prostate cancer and 
gynaecomastia, sleep apnoea and erythrocytosis (Dandona & Rosenberg, 2010).  
 
On the other hand, assisted reproductive technology is a technique where a 
processed semen sample is washed to remove prostaglandins, leukocytes, immotile 
sperm and then injected via a catheter directly into the upper uterine cavity. This 
technique allows sperm to bypass cervical mucus, elevating the chances of conception 
(Talwar, 2012). In vitro fertilization is a modified technique of assisted reproductive 
technique as both the semen sample and oocytes are taken and mixed externally for 
fertilization to happen. After an embryo is formed, it is placed into the uterus of the 
female partner. Although the fertilization rate is 70 – 85 %, the success live birth rate 
is approximately 23 % for women under age of thirty-five years old (Mansour et al., 
2014). These procedures are costly, uncomfortable and causing socio economic 
problem.  The technique is further improved in which only a single sperm is required 
for to be injected into a mature oocytes. This new technique is termed intracytoplasmic 
sperm injection. This technique greatly relies on the viability of the spermatozoon, 
quality of the oocyte and the ability of the oocyte to tolerate intracytoplasmic 
manipulation (Merchant et al., 2011). The reported success lives birth rate for 
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intracytoplasmic sperm injection (20 %) is about the same with in vitro fertilization 
(Mansour et al., 2014).  
 
1.2 Tongkat Ali (Eurycoma longifolia) 
Eurycoma longifolia is an indigenous, slender, evergreen herbal plant found in 
Southeast Asia region such as Malaysia, Indonesia, Vietnam and Thailand (Bhat & 
Karim, 2010). It is known as ‘Tongkat Ali’ or  ‘Penawar Pahit’ in Malaysia, ‘Pasak 
Bumi’ in Indonesia, ‘Cay ba binh’ in Vietnam and ‘Ian-don’ in Thailand (Kuo et al., 
2004). Table 1.1 shows the taxonomy of E. longifolia. 
 
Table 1.1: Taxonomy of E. longifolia (Hsuan, 1978).  





Order  Geraniales 
Family  Simaroubaceae 
Genus Eurycoma 
Species E. longifolia 
Binomial name Eurycoma longifolia Jack 
 
The plant grows slowly in sandy soil and can grow up to 15 m in height without 
branching. The leaves are long, spirally arranged and pinnate with numerous leaflets. 
Each leaf is roughly 5 to 20 cm long containing 30 to 40 lanceolate or obovate-
lanceolate leaflets. The brownish red flowers are hermaphrodite with 5 small lobes 
petals. The fruits are yellowish brown in colour when young and develop to brownish 
red gradually after two to three years of cultivation (Wizneh & Asmawi, 2014). It is 
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usually harvested after a period of at least five years by pulling out the whole plant to 
obtain its taproots which are cylindrical and yellowish-white (Bode & Dong, 2004).  
 
1.2.1 Traditional Uses 
E. longifolia is famous for its aphrodisiac properties especially among the aborigines. 
The aqueous roots extract of E. longifolia has been used locally to improve overall 
health including sexual prowess and performance, to treat fever, after birth, wounds, 
syphilis, hypertension and tuberculosis (Erasmus et al., 2012). The locals believe that 
two teaspoon of E. longifolia root decoction per day can improve sexual performance 
and help in the proper functioning of the male sex organs. The roots are usually cut 
into small parts, boiled with water and then consumed as a decoction or concoction. 
Honey, syrup and dates are added sometimes to reduce the bitter taste of the root 
extract of E. longifolia (Bhat & Karim, 2010). This plant has been marketed as a health 
supplement or fortified in food and beverages claiming to increase overall health. 
Currently, there are more than 200 products from E. longifolia including mixed 
capsules, tablets, canned or powdered beverages of tea and coffee accessible on the 
market (Rehman et al., 2016). 
 
1.2.2 Chemical constituents 
Phytochemical studies on E. longifolia lead to the isolation of new bioactive 
compounds from different parts of the plant. The plant contains mainly quassinoids, 
canthin-6-one alkaloids, squalene derivatives, tirucallene-type triterpenes, biphenyl-
neo-lignans, anthraquinones and polyacetylenes (Teh et al., 2010; Wang et al., 2017). 
To date, more than 60 compounds have been isolated from this plant and being tested 




Quassinoids are naturally occurring degraded triterpenes found in the plants of the 
Simarouboidaea subfamily of Simaroubaceae. They are categorized into different 
groups according to the number of carbon atoms forming their basic skeleton. Among 
them, the C-20 quassolidane skeleton is of larger existence and attracting intense 
attention. In fact, the National Cancer Institute discovered the potency of some C-20 
quassinoid compounds in antiluekemia activity since 1970s (Chakraborty & Pal, 2013). 
On the other hand, C-19 quassinoid displayed a wide spectrum of biological activities 
such as antiplasmodial, antimalarial, antileukemia, anti-tubercular, antiviral, 
aphrodisiac properties and insecticidal. Novel quassinoids were reported against 
antimalarial activity, antifatigue and antiangeogenesis (Al-Salahi et al., 2013; Ang et 
al., 1995; Gauthaman & Ganesan, 2008; Hamzah & Yusof, 2003). Table 1.2 shows the 
quassinoids which have been isolated from E. longifolia while Figure 1.1 displays the 











Table 1.2: Quassinoids isolated from E. longifolia (Rehman et al., 2016).  














Eurycolactone D Eurycomalide A 13β-Methyl,21-
dihydroeurycomanone 
 Eurycomalide B 12-Acetyl-13,21-
dihydroeurycomanone 
 Eurycomalide C 15-Acetyl-
13α(21)dihydroeurycomanone 
 Eurycomalide D 12,15-Diacetyl-
13α(21)dihydroeurycomanone 
 Eurycomalide E 1β,2α,15β-
Triacetyleuryccomanone 
 6-Dehydroxylongilactone Eurycomanol 
 11-Dehydroklaineanone 13β,18-Dihydroeurycomanol 
 Eurycolactone E 13β,21-Dihydroxyeurycomanol 
 Eurycolactone F 5α,14β,15β-
Trihydroxyklaineanone 
 Eurycolactone G 11-Dehydroklaineanone 
  12-epi-11-Dehydroklaineanone 
  14,15β-Dihydroxyklaineanone 
  15β-Hydroxyklaineanone 
  15β-Acetyl-14-
hydroxyklaineanone 
  5-iso-Eurycomadilactone 
  13-epi-Eurycomadilactone 











              
 
Eurycomanone (EN)                13α, 21-Dihydroeurycomanone (DHY) 
 
 
             
13α(21)-Epoxyeurycomanone (EP)        Eurycomanol (EL) 
 
 
Figure 1.1: Chemical structure of four major quassinoid in E. longifolia: (A) 
eurycomanone, (B) 13α, 21-dihydroeurycomanone, (C) 13α(21)-epoxyeurycomanone 











Alkaloid is a naturally occurring organic compound containing basic nitrogen atom 
found mainly in plant. Some well-known alkaloid includes morphine, quinine, nicotine 
and ephedrine. These alkaloid possess important pharmacological activities such as 
antimalarial, anti-inflammatory and antioxidant. Table 1.3 shows the alkaloids isolated 
from E. longifolia. 
 
Table 1.3: Alkaloids isolated from E. longifolia. 
Alkaloids References 
Canthin-6-one (Choo & Chan, 2002; 
Mitsunaga et al., 1994) 
4-Hydroxy-5-methoxycanthin-6-one (Kuo et al., 2004) 
10-hydroxycanthin-6-one (Chan et al., 1986) 













Β-Carboline-1-propionic acid  
5-Hydroxymethylcanthin-6-one  




1-Hydroxy-9-methoxycanthin-6-one (Kuo et al., 2003) 
5-Hydroxymethyl-9-methoxycanthin-6-one  
8-Hydroxy-9-methoxycanthin-6-one  
n-Pentyl β-carboline-1-propionic acid  
Methyl β-carboline-1-carboxylate  




1.2.2(c) Squalene Derivatives 
Squalene derivatives isolated from E. longifolia included eurylene, longilene peroxide 
(Itokawa et al., 1991), 14-deacetyl eurylene and teurilene (Morita et al., 1993). 
 
1.2.2(d) Tricullane-type triterpenes 
Tricullane-type triterpenoids isolated from E. longifolia included niloticin, 
dihydroniloticin, piscidinol A, bourjotinolone A, melianone, 3-episapeline A and 
hispodine (Itokawa et al., 1992).  
 
1.2.2(e) Biphenylneolignans 
Biphenylneolignans isolated from E. longifolia were 2,2’-dimethoxy-4’-(-3-hydroxy-
1-propenyl)-4-(1,2,3-trihydroxypropyl) diphenyl ethers, 2-hydroxy-3,2’,6’-
trimethoxy-4’-(2,3-epoxy-1-hydroxypropyl)-5-(3-hydroxy-1-propenyl)biphenyl and 
2-hydroxy-3,2’-dimethoxy-4’-(2,3-epoxy-1-hydroxypropyl)-5-(3-hydroxy-1-   
propenyl) biphenyl (Morita et al., 1992).  
 
1.2.2(f) Anthraquinones and anthraquinones glycosides  
Anthraquinones and anthraquinones glycosides isolated from E. longifolia were 
chrysophanol, parietin, emodin, emodin-8-O-β-glucoside, aloeemodin-8-O-β-
glucoside, chrysophenol-1-O-β-glucoside, chryso-phenol-8-O-β-glucoside and 
parietin-8-O-β-glucoside (Lin et al., 2001).   
 
1.2.2(g) Polyacetylenes 
Polyacetylenes were found in E. longifolia recently. The new compounds isolated were 
longifolione A, B, C, D and E  (Wang et al., 2017).  
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1.2.3 Biological activities 
Pharmacology studies which have been carried out on E. longifolia included 
aphrodisiac activity, anti-malarial, cytotoxicity and ergogenic effect. 
 
1.2.3(a) Aphrodisiac and anti-infertility activities 
E. longifolia root extract has been proven scientifically to improve male libido and 
sexual desire conforming to the traditional belief. Earlier animal studies revealed that 
sexually unexperienced rats treated with E. longifolia extract and fractions displayed 
an increase in sexual desire and motivation compared to normal control group (Ang & 
Sim, 1998). Besides that, middle-aged male rats showed prominent aphrodisiac effect 
after force fed with E. longifolia extracts and fractions, twice daily for 10 days (Ang 
& Lee, 2002). A consecutive in vivo study was carried out by evaluating the sperm 
quality of male rats after feeding on standardized E. longifolia methanolic extract that 
contain mainly eurycomanone (EN), 13α,21-dihydroeurycomanone (DHY), 
eurycomanol (EL) and 13α(21)-epoxyeurycomanone (EP). It was concluded that the 
sperm count, morphology and plasma testosterone level increased significantly in a 
dose dependant manner (Chan et al., 2009). Human trial on E. longifolia also reported 
that 75 sub-fertile patients given 200 mg of E. longifolia water extract daily for 3 
months showed significant improvement in all semen parameters and 17 % of them 
had spontaneous pregnancy (Tambi & Imran, 2010). Even patients with late onset 
hypogonadism have improved sign of ageing male symptoms and increased serum 
testosterone level after consuming 200 mg of standardized E. longifolia water extract 




Thus, a more intensive study was continued to determine the active constituents 
contributing to the aphrodisiac effect in E. longifolia. It was proven scientifically that 
the major quassinoids in E. longifolia were the active functional compound in 
enhancing male libido. A study was conducted by comparing the efficacy of TA water 
extract and its fraction (TAF2) in increasing rat sperm count. The fraction TAF2 was 
collected through a patented resin column chromatography fractionation technology 
(Chan et al., 2006). The TA water extract and TAF2 with adjusted dosage to similar 
quassinoids content feeding to male rats reported an almost similar increment in sperm 
concentration and morphology (Low et al., 2013a). Correspondingly, the up-to-date 
research on E. longifolia reported that male rats given E. longifolia quassinoid-rich 
extract orally for 48 days has a significant higher sperm concentration than the other 
group feeding on E. longifolia quassinoid-poor extract (Ebrahimi et al., 2016).  
 
1.2.3(b) Antimalarial property 
Antiplasmodial activity from E. longifolia root extract has been reported since early 
1980s. Organic and water extracts of E. longifolia together with the isolated 
compounds 10-hydroxycanthin-6-one, eurycomalactone, eurycomanone and 
eurycomanol were tested in vitro on Thailand strain (K-1) of Plasmodiun falciparum. 
All of the isolated compounds showed inhibition activity towards P.  falciparum 
except the alkaloid 10-hydroxycanthin-6-one. It is noteworthy that the inhibition 
activity of eurycomanone was two-fold greater than the standard drug chloroquine 
diphosphate which is a known medication to prevent and treat malarial (Chan et al., 
1986). Correspondingly, another study on the antimalarial properties of E. longifolia 
reported that eurycomanone was the most active compound among the isolated 
compounds (β-carboline-propionic acid, 18-dehydro-6α-hydroxyeurycomalactone, 
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eurycomanol, eurycomanone and chloroquine diphosphate) due to the presence of 
exomethylene bridge between atom C-8 and C-11 in eurycomanone (Yusuf et al., 
2013). The potency of eurycomanone as an antimalarial agent was further supported 
by continuous investigation. Once more, eurycomanone reported stronger inhibition 
(IC50 = 14.9 ng/mL) against W2 P. falciparum clones than chloroquine (IC50 = 75.3 
ng/mL) but a lower inhibition activity (IC50 = 34.0 ng/mL) against D6 P. falciparum 
clones compared to chloroquine (IC50 = 2.72 ng/mL) (Kuo et al., 2004). 
 
Tongkat Ali extract containing three main quassinoids, eurycomanone, 13α,21-
dihydroeurycomanone and 13α(21)-epoxyeurycomanone were investigated against 
antiplasmodial activity and showed good inhibition towards P.  falciparum. The author 
suggested that it might be due to the synergistic effect between the three quassinoids 
or presence of other unidentified compound (Wernsdorfer et al., 2009).   
 
1.2.3(c) Anti-proliferative 
In 1992, six quassinoids and seven tricullane-type triterpenes were isolated from E. 
longifolia extract and tested in vitro against P388 (leukemia cells line) and KB 
(carcinoma cells line) for the evaluation of their cytotoxicity. Interestingly, all of the 
isolated compounds showed good cytotoxicity activity against the cell line with 6α-
hydroxyeurycomalactone being the most potent against P388 cells and 14,15β-
dihydroxyklaineanone being the most potent against KB cells (Itokawa et al., 1992). 
The anti-proliferative activity of 14,15β-dihydroxyklaineanone was further supported 
by another in vitro anti-tumor study induced by Epstein-Bar virus activation where 
14,15β-dihydroxyklaineanone displayed IC50 of 9.0 µM which was much higher than 
quercetin (23.0 µM) and β-carotene (30.0 µM) (Jiwajinda et al., 2002).  However, it 
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was suggested that the C19 quassinoids were more potent against P388 cells line as the 
IC50 of 6-dehydroxylongilactone and 7α-hydroxyeurycomalactone were 0.11 and 0.66 
µg cm-3 which were higher than 15-acetyl-13α(21)-epoxyeurycomanone (6.6 µg cm-3) 
and 12,15-diacetyl-13α(21)-epoxyeurycomanone  (7.2 µg cm-3) (Morita et al., 1993). 
Twenty-four quassinoids isolated from E. longifoia were also evaluated on HT-1080 
(human fibrosarcoma cell line) and the result showed that eurycomalactone, 14,15β-
dihydroxyklaineanone and 13α,21-dihydroeurycomanone with IC50 of 0.98, 1.1 and 
0.93 µM were the most cytotoxic quassinoids among the isolated compounds toward 
HT-1080 cell lines (Miyake et al., 2009).  
 
Later, research focused on various E. longifolia extracts and fractions. It was 
reported that the MeOH, n-butanol and chloroform extracts of E. longifolia were 
cytotoxic against KB (epidermoid carcinoma), DU-145 (prostate cancer), RD 
(rhabdosarcoma), MCF-7 (breast cancer) and CaOV-3 (ovarian cancer) cell lines but 
contradictorily, the aqueous extract did not show any sign of toxicity in the respective 
study (Nurhanan et al., 2005). Then, all fractions (TAF2, TAF3, TAF1 and TAF4) 
from E. longifolia tested against HS27 cells lines showed high toxicity (IC50 < 20 
µg/mL) against HS27 mammalian cells and moderate cytotoxicity activity against 
Vero cell lines except fraction TAF3 via MTT assay (Kavitha et al., 2010). 
Consecutively, study conducted on the three fraction (TAF2, F3 and F4) from E. 
longifolia evaluated against K-562 leukemic cells line in vivo and in vitro reported that 
fraction TAF2 showed the most potent anti-proliferative activity (Al-Salahi et al., 
2014). Further ex vivo and in vivo studies on TAF2 revealed its anti-angiogenic 
potential whereby TAF2 significantly suppressed the development of microvessels in 
rat aorta and inhibited the angiogenesis of human umbilical vein endothelial cells 
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(HUVEC) (Al-Salahi et al., 2013). Those studies suggested that TAF2 was worth of 
further study particularly in investigating the bioactive compounds that cause anti-
proliferative activity.   
 
The major quassinoid, eurycomanone from TAF2 fraction was isolated and 
reported significant suppression on the expression of the A549 lung cancer cells 
(Wong et al., 2012). The mechanism of action was studied and reported that 
eurycomanone inhibited 1kBβ phosphorylation and upstream mitogen activated 
protein kinase (MAPK) signalling, causing regression in the proliferation of Jurkat 
(human T lymphocyte cell) and K562 cell (human erythroleukemic cell line) (Hajjouli 
et al., 2014) 
 
1.2.3(d) Ergogenic property 
Human trial involving male and female elderly between 57-72 years old were carried 
out to study the ergogenic effect of Physta E. longifolia extract. Both male and female 
participants taking 200 mg of the extracts twice daily for five weeks demonstrated 
significant increase in serum testosterone concentrations, muscle strength and muscle 
mass (Henkel et al., 2014). The increase of testosterone level inhibited adipogenesis, 
thereby increasing lean body mass and physical functions (Herbst & Bhasin, 2004). 
Earlier study also reported 37 % increase in testosterone level and improvement in 
psychological mood parameters after supplemented with standardized hot-water 
extract of E. longifolia for four weeks in 63 subjects including 32 men and 31 women 
(Talbott et al., 2013). This clearly pointed out the effectiveness of E. longifolia extract 





An acute oral toxicity study showed that the LD50 of E. longifolia aqueous extract 
(containing more than 22% eurypeptide, 40 % glycosaponin and 1 % eurycomanone) 
was more than 5000 mg/kg in rats with no pathological changes (Shuid et al., 2011). 
Therefore, from this study, it can be postulated that the LD50 of EN was equivalent to 
50 mg/kg. However, in subacute toxicity study for 28 days, it was reported that some 
of the animals displayed liver toxicity at 1200 mg/kg and 2400 mg/kg of E. longifolia 
aqueous extract (Shuid et al., 2011). To date, this was the only acute and subchronic 
toxicity studies on E. longifolia aqueous extract. Another acute toxicity conducted by 
Li et al. (2013) reported that the acute oral LD50 of E. longifolia root powder was more 
than 6000 mg/kg. As for subchronic toxicity, the same author reported that rats feeding 
on 2000 mg/kg of E. longifolia root powder did not show significant changes in body 
weight hematology, serum biochemistry, urinalysis, macropathology or hispathology. 
Moreover, the treatment with E. longifolia root powder for 4 weeks and 13 weeks 
significantly reduced blood urea nitrogen, lactose dehydrogenase, creatinine, and 
cholesterol in male rats (Li et al., 2013). The discrepancy in toxicity studies might be 
due to differences from source of plant materials, extraction methods and experiment 
designs. From the above studiesan aqueous dose of one tenth of 1200 mg.kg can be 
considered as relatively safe for experimental studies. 
 
A reproductive and development toxicity study on E. longifolia  aqueous 
extract (PHYSTA), a product of Phytes Biotek Sdn Bhd, Malaysia were carried out in 
compliance with OECD Principles of Good Laboratory Practice and OECD Guidelines 
for testing of Chemicals, Section 4 No 421. The authors concluded that E. longifolia 
product containing 0.8 – 1.5 % eurycomanone at the dosages of 250, 500 and 1000 
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mg/kg did not show signs of toxicity in rats after histopathology and pathology studies 
(Ming et al., 2015). A patented, standardized E. longifolia extract, TAF273 (Chan & 
Low, 2008) was also tested on reproductive toxicity and two-generation teratology 
studies. Results indicated that the females rats treated with TAF273 showed significant 
increase in fertility index and litter size than non-treated female rats (Low et al., 2014). 
In this study, Low et al. (2014) also reported that the LD50 and no-observed adverse 
effect level (NOAEL) of TAF273 1293 mg/kg and 100 mg/kg, respectively. 
 
1.3 Macroporous resin 
Macroporous resin is a highly cross-linked, lipophilic polymeric adsorbent prepared 
from the polymerization of styrene-divinylbenzene or acrylic-divinylbenzene. 
However, most of the macroporous resin is based on polystyrene matrix. There are 
wide variations in surface area, functionality and porosity among the macroporous 
resin adsorbents (Mitsubishi Chemical, 2017). The resin beads are essentially solid by 
having a permanent well developed and homogenous porous structure with pore 
diameters up to several hundred angstroms (Å). The amount of crosslinking depends 
on the proportion of different monomers used in the polymerization step, practically 
ranging between 4 and 16 %. Low level of monomers (< 1 %) is undesirable as it 
produces mechanically weak networks that could easily damage by heating, handling 
or solvent shock (Mei & Czarnik, 2002). Resin with very low crosslinking also tends 
to be more hydrated and changed dimensions markedly depending on which ions are 
bound. Generally, the surface area of macroporous resin which ranges between 100 to 
600 m2/g offer high adsorption capacities. Macroporous resin has been widely used as 
a separation medium in chemical synthesis, pharmaceutical research, food industries, 
mining, agriculture and industrial water treatment. The advantages of using 
21 
 
macroporous resins are high adsorption capacity, relatively low cost, chemically stable, 
easy regeneration and high recovery (Soto et al., 2011). Macroporous resin can be 
further categorized as ion exchange resin, chelating resins and non-polar synthetic 
resins according to the functional group that have been added to the backbone 
structures during condensation or polymerization. Table 1.4 shows the physical 
parameters of various macroporous resins. 







AmberliteXAD-2 ≥ 300 18 Rohm&Haas (USA) 
AmberliteXAD-4 ≥ 750 10 Rohm&Haas (USA) 
AmberliteXAD-16 ≥ 800 15 Rohm&Haas (USA) 
AmberliteXAD-761 150–250 60 Rohm&Haas (USA) 
Diaion HP-20 ≥ 600 40 Mitsubishi Chemical 
(Japan) 
Diaion HP-21 ≥ 570 16 Mitsubishi Chemical 
(Japan) 
Diaion HP-2MG ≥ 500 40 Mitsubishi Chemical 
(Japan) 
Sepabeads SP-825 ≥ 1000 11 Mitsubishi Chemical 
(Japan) 
Sepabeads SP-850 ≥ 1000 7.6 Mitsubishi Chemical 
(Japan) 
Sepabeads SP70 ≥ 800 14 Mitsubishi Chemical 
(Japan) 
Sepabeads SP700 ≥ 1200 18 Mitsubishi Chemical 
(Japan) 
Sepabeads SP207 ≥ 630 21 Mitsubishi Chemical 
(Japan) 
NKA-9 250–290 12-18 Cangzhou Bonchem (China) 
NK-110 ≥ 500 16 Cangzhou Bonchem (China) 
HA ≥ 800 4-10 Cangzhou Bonchem (China) 
X-5 500–600 29-30 Cangzhou Bonchem (China) 
ADS-5 ≥ 550 20-30 Cangzhou Bonchem (China) 
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An ion exchange resin is a polymer with electrically charged sites at which one 
ion may replace another. The monomers are usually functionalized through chemical 
reactions before polymerization into beads (Fritz et al., 2010). It can be divided into 
two broad categories, namely cation exchange resin and anion exchange resins. Strong 
cation exchange resins containing sulfonic acid groups or the corresponding salts as 
their functional groups. Weak cation exchange resins contain carboxylic acid groups 
or the corresponding salts as their functional groups. Strong anion exchange resins 
containing quaternary ammonium groups that impart higher basicity. Weak cation 
exchange resins containing ammonium chloride or hydroxide groups (Mitsubishi 
Chemical, 2017). Ion exchange resins are primarily used in water treatment 
applications, demineralization and decolourization.   
 
On the other hand, non-polar macroporous resin does not have ionic functional 
groups and is mainly build-up of diethylbenzene. The adsorption mechanism of 
polystyrene benzene macroporous resin was dependant on the hydrophobic and 
electrostatic interactions (Lailiang, 2017). It is usually used as a reverse phase 
adsorbent eluted with mobile phase in descending polarity. Synthetic adsorbent resin 
has been developed since 1960 in United State of America. Later on, China and Japan 
also manufactured macroporous resin according to market requirements. Synthetic 
resins were widely used because they facilitate a cheap and effective chemical 
regeneration process (Lin & Juang, 2009). Nonpolar macroporous resin can be build 
out by different polymers for selective separation of organic compounds. There are 
adsorbent of styrene body, adsorbent of brominated styrene body and adsorbent of 
methacryle body (Mitsubishi Chemical, 2017).  
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Selection of resin for this study is based on the molecule structure of quassinoids 
and prediction of its possible interaction. Synthetic absorbent were chosen because 
they were typically used in analytical and preparative chromatographic separation for 
hydrophilic compounds. Quassinoids are polar, hydrophilic compound with molecular 
weight around 400. By utilizing the polarity difference of the mobile phase, the 
impurities could be separated out the compound of interest. Adsorbent resins of styrene 
body such as Diaion HP series have strong adsorption ability as they form π-π 
interaction bond with the adsorbed sample. They are commonly used in food and 
pharmaceutical industry for protein purification, decolourization of various sugar 
solutions, phenol removal and chemical separation purposes. Therefore Diaon HP-20 
was chosen as one of the adsorbent resin in this study.  
 
On the other hand, the modified synthetic resins made up of the brominated 
styrene backbone (Sepabeads SP series) have a stronger adsorption ability in adsorbing 
low hydrophobic materials when compared to adsorbent of styrene body. This is due 
to the high hydrophobicity property of the brominated styrene body in nature that has 
greater selectivity towards the non-polar molecules (Mitsubishi Chemical, 2017). The 
electron accepting effect of the added bromine increases the hydrophobicity of the 
chemically modified synthetic adsorbent. Due to this properties, Sepabeads SP-207 
can absorb many compounds very strongly. In this study, the targeted compound DHY 
was less polar than EN. Therefore, Sepabeads resin was selected as one of the 






Spermatogenesis is the development of spermatozoa involving mitosis and meiosis 
that occur in seminiferous tubules located in the testis. Mitosis is a cell process of 
division that results in two genetically identical daughter cells developing from parent 
cells while meiosis involves the division of germ cell into four gametes, each 
possessing half the number of chromosomes of the original cell. Seminiferous tubules 
contain an active population of highly dividing and self-sustaining germ cell, an 
embryonic cell with the potential of developing into a gamete. In human, 
spermatogenesis take about 65-75 days (Tortora & Derrickson, 2009) while in rat, the 
complete process from spermatogonia to spermatozoa takes about 48-52 days 
(Lohmiller & Swing, 2006). Spermatogenesis can be divided into three important 
phases which are primary spermatocytogenesis, secondary spermatocytogenesis and 
spermiogenesis (Sharma & Agarwal, 2011). 
 
 During primary spermatocytogenesis, the primitive stem cells, 
spermatogonium proliferate to form diploid spermatocyte. In human, several 
spermatozoa cell types have been identified (A-0 through A-4, intermediate [IN], and 
B). Mitosis ends when a B spermatogonium yields two primary spermatocytes. 
Subsequently, the primary spermatocytes type B spermatogonia enter the prophase of 
meiosis and divide through to form haploid secondary spermatocytes (Tortora & 
Derrickson, 2009) (Figure 1.2). During spermiogenesis, the round spermatid, which 
arises from the secondary spermatocytogenesis meiotic division, undergoes a series of 
complex cytological events and transformed into spermatozoon. The acrosome is 
derived from the Golgi apparatus. Centrioles (points of organization of spindle fibers) 
migrate to a post nuclear region after the completion of meiosis. This transformation 
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involves nuclear condensation, formation of the acrosomal cap, and development of a 




























Figure 1.2: The spermatogenesis cycle. 
